Predictive medicine: incipient reality orfata morgana?
- 15 June 2007
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 212 (4), 353-355
- https://doi.org/10.1002/path.2191
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Genomic signatures to guide the use of chemotherapeuticsNature Medicine, 2006
- Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trialNature Clinical Practice Oncology, 2006
- The US Food and Drug Administration perspective on cancer biomarker developmentNature Reviews Cancer, 2006
- Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. A reviewVirchows Archiv, 2006
- Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survivalOncogene, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayBlood, 2004
- Expression profiling predicts outcome in breast cancerBreast Cancer Research, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000